Prevention of nausea & vomiting associated w/ moderately emetogenic cancer chemotherapy Adult
8 mg twice daily. Administer 1st dose 30 min prior to chemotherapy w/ subsequent dose 4-8 hrly. Thereafter, 8 mg twice daily for 1-2 days after completion of chemotherapy. Childn 4-12 yr
4 mg 3 times daily. Prevention of nausea & vomiting associated w/ radiotherapy
8 mg 1-2 hr prior to radiotherapy w/ subsequent doses 8 hrly after the 1st dose. Post-op nausea & vomiting
16 mg as single dose 1 hr prior to anaesth induction.